CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 401 enrolled
Drug / intervention
Sumatriptan 100 mg +1 moredrug
Likely dose
Sumatriptan 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00449787
NCT00449787Phase 4Completed
CompareCT.gov

A Randomized Clinical Trial to Compare Naproxen and Sumatriptan for Headache Patients Discharged From the Emergency Department (ED)

Montefiore Medical Center·interventional·Posted Mar 21, 2007·Updated May 31, 2018

In Brief

A Phase 4 clinical trial evaluating Sumatriptan 100 mg and Naproxen for Migraine and 2 related conditions. Completed, enrolled 401 participants across 2 sites.

Detailed Summary

2/3 of patients discharged from an emergency department after treatment for an acute headache will still be bothered by headache within 24 hours of emergency department (ED) treatment. The goal of this study is to compare two medications, naproxen and sumatriptan, to determine which is better for the treatment of recurrent headache within 24 hours of emergency department discharge.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine, Tension-type Headache, Primary Headache Disorder
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 21, 2007
Enrollment StartMar 1, 2007
Primary CompletionJul 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 19.3 years ago

Interventions

Sumatriptan 100 mgdrug

Sumatriptan 100mg tablet

Naproxendrug

Naproxen 500mg tablet